Brain perfusion SPECT correlates with CSF biomarkers in Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00259-009-1285-8PMID 19820929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain Metabolic Correlates of Cerebrospinal Fluid Beta-Amyloid 42 and Tau in Alzheimer’s Disease

  2009cited by this paper
• Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.

  2009cited by this paper
• Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease

  2009cited by this paper
• Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer’s disease

  2009cited by this paper
• Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

  2009cited by this paper
• CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease.

  2008cited by this paper
• Increasing CSF phospho-tau levels during cognitive decline and progression to dementia.

  2008cited by this paper
• CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer’s disease

  2008cited by this paper
• CSF neurofilament proteins in the differential diagnosis of dementia

  2007cited by this paper
• Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

  2007cited by this paper
• Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

  2006cited by this paper
• CSF markers for incipient Alzheimer's disease.

  2003cited by this paper
• Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

  2002cited by this paper
• Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.

  2002cited by this paper
• Correlation of rCBF (SPECT), CSF tau, and congnitive function in patients with dementia of the Alzheimer's type, other types of dementia, and congrol subjects

  2001cited by this paper
• Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease.

  2000cited by this paper

• Time‐encoded ASL reveals lower cerebral blood flow in the early AD continuum

  2024cites this paper
• Microvascular Perfusion Imaging in Alzheimer's Disease.

  2024cites this paper
• Perfusion Imaging and Inflammation Biomarkers Provide Complementary Information in Alzheimer’s Disease

  2023cites this paper
• Gray matter hypoperfusion is a late pathological event in the course of Alzheimer’s disease

  2022cites this paper
• Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum.

  2021cites this paper
• Cerebral hypoperfusion is a late pathological event in the course of Alzheimer's disease

  2021cites this paper
• Convergent and Discriminant Validity of Default Mode Network and Limbic Network Perfusion in Amnestic Mild Cognitive Impairment Patients

  2021cites this paper
• Neuroimaging Findings in Mild Cognitive Impairment

  2020cites this paper
• Serum levels of proteins involved in amyloid-β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment

  2018cites this paper
• Two-Photon Imaging Reveals Capillary Occlusions are Responsible for Reduced Brain Blood Flow and Cognitive Decline in Alzheimer’s Disease Mouse Models

  2017cites this paper
• On the early diagnosis of Alzheimer's Disease from multimodal signals: A survey

  2016cites this paper
• CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly Running title : CSF and CBF in healthy elderly

  2016cites this paper
• Open Archive TOULOUSE Archive Ouverte (OATAO)

  2014cites this paper
• Does CSF p-tau181 help to discriminate Alzheimer’s disease from other dementias and mild cognitive impairment? A meta-analysis of the literature

  2014cites this paper
• Multimodal neuroimaging on neurodegenerative disorders using the hybrid PET/MRI technique

  2014cites this paper
• Assessment of CSF Aβ42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies.

  2014cites this paper
• A new paradigm for testing AD drugs – neuroimaging biomarkers as surrogate outcomes homologous in animals and humans

  2013cites this paper
• The relationship between the diagnosis method of neuronal dysfunction (DIMENSION) and brain pathology in the early stages of Alzheimer's disease

  2013cites this paper
• CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly

  2012cites this paper
• Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.

  2012cites this paper
• Significant correlation between cerebral hypoperfusion and neuropsychological assessment scores of patients with mild cognitive impairment

  2012cites this paper
• Correlation between neuropsychological tests and hypoperfusion in MCI patients: anatomical labeling using xjView and Talairach Daemon Software

  2012cites this paper
• CSF tau markers are correlated with hippocampal volume in Alzheimer's disease.

  2012cites this paper
• Intérêt du dosage des biomarqueurs du LCR dans les démences dégénératives

  2011cites this paper
• Brief communication CSF tau markers are correlated with hippocampal volume in Alzheimer's disease

  2011cites this paper
• Use of fuzzy edge single-photon emission computed tomography analysis in definite Alzheimer's disease - a retrospective study

  2010cites this paper
• Neurobiology of Aging

  year unknowncites this paper